CFML
BIIB icon

COMPASS FINANCIAL MANAGEMENT LLC’s Biogen BIIB Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216 Buy
+1
New +$191 ﹤0.01% 1478

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's BIIB Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Biogen (BIIB) in Q2 2026: 1 share worth $216. The stake represents ﹤0.01% of the portfolio and ranks #1478 among its holdings.

746 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 1 share of Biogen worth $216 as of Q2 2026.
  • Biogen was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • Biogen made up ﹤0.01% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #1478 holding.
  • 746 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.